A practice that sends specimens on to another laboratory needs a referral process covering seven points: domestic referral laboratories hold both NPAAC accreditation and ISO 15189; overseas laboratories with ISO 15189 or equivalent accreditation are chosen ahead of unaccredited ones; the referral laboratory's clinicians and the patient are told what they need to know, including that an overseas test attracts no Medicare rebate and its cost falls on the patient, and about consequences such as where data will sit; packaging, transport and handover of specimens sent abroad stay the sending practice's responsibility; the risks of using a referral laboratory, turnaround time among them, are managed; there is a route for the reports to come back; and the two laboratories agree in writing which of them will communicate a critical result.
This control maps to 1 controls across 1 other frameworks. If you already hold one of them, the evidence you collected for it is the starting point here rather than new work.
Every mapping shown was judged rather than inferred from wording similarity, and the ones that failed review are published too. See the coverage reports and what was rejected.
The graph holds this control, the 1 it maps to, and the evidence behind each claim, over MCP and REST.